1-哌啶-1-丁酮 | 4637-70-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-哌啶-1-丁酮
• 英文名称: 1-(piperidin-1-yl)butan-1-one
• 英文别名: N-Butyryl-piperidin；1-butyrylpiperidine；Piperidine, 1-(1-oxobutyl)-；1-piperidin-1-ylbutan-1-one
• CAS: 4637-70-1
• 化学式: C₉H₁₇NO
• mdl: MFCD00460375
• 分子量: 155.24
• InChiKey: QANVSPFERJBPTO-UHFFFAOYSA-N

物化性质

• 沸点：
  60-65 °C(Press: 0.7 Torr)
• 密度：
  0.959±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  1-哌啶-1-丁酮 在 1,4-二氧六环 、 copper oxide-chromium oxide 作用下， 260.0 ℃ 、29.42 MPa 条件下， 生成 1-丁基哌啶
  参考文献：
  名称：

  Hydrogenation of Hydroxyamides

  摘要：

  DOI：

  10.1021/ja01876a012
• 作为产物：
  描述：

  2-(Benzenesulfonyl)-1-piperidin-1-ylbutan-1-one 在 disodium hydrogenphosphate 、 sodium amalgam 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以86%的产率得到1-哌啶-1-丁酮
  参考文献：
  名称：

  Conversion of Carbamates to Amidosulfones and Amides. Synthesis of the [¹⁴C]-Labeled Antiobesity Agent Ro23-7637.

  摘要：

  [GRAPHICS]Carbamates of primary and secondary amines react with the dianion of methyl phenyl sulfone to yield amidosulfones. Alylation of the amidosulfone followed by reductive removal of the sulfonyl residue gives an amide.

  DOI：

  10.1021/ol020062p

文献信息

• Preparation of amides mediated by isopropylmagnesium chloride under continuous flow conditions
  作者：Juan de M. Muñoz、Jesús Alcázar、Antonio de la Hoz、Ángel Díaz-Ortiz、Sergio-A. Alonso de Diego

  DOI：10.1039/c2gc35037h

  日期：——

  mediated by Grignard reagents (the Bodroux reaction) is described. The procedure can be applied to a wide variety of primary and secondary amines and anilines, as well as to aromatic and aliphatic esters. The flow approach leads to improved yields and selectivities in the reaction, which has a sustainable purification procedure and a simple scale-up. This reaction represents an efficient and green alternative

  Direct的安全，绿色和功能组容忍的流程版本 酰胺 介导的键形成 格氏试剂（Bodroux反应）被描述。该程序可应用于各种各样的主要和仲胺 和 苯胺以及芳香族和脂肪族 酯类。流动方法可提高反应的收率和选择性，并具有可持续的纯化程序和简单的放大规模。该反应代表了烷基铝和金属催化方法的一种有效而绿色的替代方法。
• ACETYL CoA CARBOXYLASE INHIBITORS
  申请人：Chang Edcon

  公开号：US20090253725A1

  公开（公告）日：2009-10-08

  The present invention relates to acetyl coenzyme-A carboxylase (“ACC”) inhibiting compounds of the formula wherein the variables are as defined herein. In particular, the present invention relates to ACC1 and/or ACC2 inhibitors, compositions of matter, kits and articles of manufacture comprising these compounds, methods for inhibiting ACC1 and/or ACC2, and methods of making the inhibitors.

  本发明涉及乙酰辅酶A羧化酶（“ACC”）抑制化合物，其化学式如下 其中变量如本文所述定义。特别是，本发明涉及ACC1和/或ACC2抑制剂，包含这些化合物的物质、套件和制品，抑制ACC1和/或ACC2的方法，以及制造抑制剂的方法。
• INHIBITORS OF INFLUENZA VIRUSES REPLICATION
  申请人：Charifson Paul S.

  公开号：US20120171245A1

  公开（公告）日：2012-07-05

  Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

  抑制生物样本或患者中流感病毒的复制、减少生物样本或患者中流感病毒量以及治疗患者流感的方法，包括向所述生物样本或患者施用有效量的由结构公式（I）表示的化合物： 或其药用可接受盐，其中结构公式（IA）的值如本文所述。由结构公式（IA）或其药用可接受盐表示的化合物，其中结构公式（IA）的值如本文所述。药物组合物包括有效量的上述化合物或其药用可接受盐，以及药用可接受载体、佐剂或车辆。
• Imidazolothiazole compounds for the treatment of disease
  申请人：Bhagwat Shripad

  公开号：US20070232604A1

  公开（公告）日：2007-10-04

  Compounds, compositions and methods are provided for modulating the activity of receptor kinases and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by receptor kinases.

  提供了用于调节受体激酶活性以及用于治疗、预防或改善由受体激酶介导的一种或多种疾病或紊乱症状的化合物、组合物和方法。
• Ruthenium(II)-NNN-Pincer-Complex-Catalyzed Reactions Between Various Alcohols and Amines for Sustainable C−N and C−C Bond Formation
  作者：Milan Maji、Kaushik Chakrabarti、Bhaskar Paul、Bivas Chandra Roy、Sabuj Kundu

  DOI：10.1002/adsc.201701117

  日期：2018.2.15

  were synthesized from 2‐aminobenzyl alcohols and secondary alcohols. The effectiveness of this protocol was further extended by successfully synthesizing 2‐alkylaminoquinolines in a one‐pot fashion from amino alcohol, aliphatic nitriles, and alcohols. Gram scale synthesis of various compounds was also investigated to demonstrate the synthetic applicability of this methodology.

  空气和湿气稳定的基于2-羟基吡啶的双官能钌NNN-钳子络合物在温和条件下催化胺的高效（TON = 42840）N-烷基化。出人意料的是，对于环状仲胺，该方法仅选择性地产生酰胺。值得注意的是，几种胺的N-甲基化是通过使用甲醇作为绿色甲基化剂实现的。此外，由于催化剂负载量较低（0.2摩尔％）和反应时间较短（6小时），因此由2-氨基苄醇和仲醇合成了许多取代的喹啉。通过从氨基醇，脂肪族腈和醇中一锅法成功合成2-烷基氨基喹啉，进一步扩大了该协议的有效性。